Non-interaction Study Between Pregabalin and Tramadol, Administered Individually or Combination, in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg
- First Posted Date
- 2022-05-25
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 30
- Registration Number
- NCT05389150
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Pregabalin/Tramadol Combination Versus Pregabalin in Acute Pain of Neuropathic Origin
Phase 3
Completed
- Conditions
- Neuropathic Pain
- Interventions
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 110
- Registration Number
- NCT05324059
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Ciudad de México, Mexico
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
Completed
- Conditions
- Seborrheic DermatitisPsoriasis of Scalp
- Interventions
- Other: Allantoin/ Coal Tar/ ClioquinolOther: Allantoin/ Coal Tar/ Clioquinol/ Triclosan
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 90
- Registration Number
- NCT05105139
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 36
- Registration Number
- NCT05090449
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Comparison of Bioavailability of Dexketoprofen-Vit B vs Dexketoprofen, in Healthy Subjects, Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Fixed dose Dexketoprofen-Vitamin B Complex
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2021-09-05
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 36
- Registration Number
- NCT05027126
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Ciudad de Mexico, Mexico City, Mexico
Efficacy and Safety of Dexketoprofen/Vitamin B Vs Dexketoprofen for Post-traumatic Cervical Sprain Grade I-II
Phase 3
Completed
- Conditions
- Acute Low Back Pain
- Interventions
- Drug: Dexketoprofen/Vitamin B
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 174
- Registration Number
- NCT05001555
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain
Phase 3
Completed
- Conditions
- Acute Low Back Pain
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 124
- Registration Number
- NCT04968158
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes
Phase 3
Suspended
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2021-06-29
- Last Posted Date
- 2021-06-29
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 500
- Registration Number
- NCT04943692
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension
Phase 3
Completed
- Conditions
- Essential Arterial Hypertension
- Interventions
- Drug: Losartan/Chlorthalidone in fixed dose
- First Posted Date
- 2021-06-15
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 163
- Registration Number
- NCT04927299
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program
Completed
- Conditions
- Tuberculosis
- Interventions
- Drug: Rifampicin/ Isoniazid/ Pyrazinamide/ Ethambutol
- First Posted Date
- 2021-06-08
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 47
- Registration Number
- NCT04916899
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
© Copyright 2025. All Rights Reserved by MedPath